Station 41 New Ventures provides technology programs with the corporate structure and resources to advance further via non-dilutive and equity funding. New Ventures was launched by SR in 2022, which implemented a program prioritization rubric using commercial, regulatory, and scientific diligence processes aligned to venture capital standards.

The New Ventures program will launch three cohorts annually, aligned to NIH non-dilutive funding deadlines. In addition to seeding and prioritizing further development of core technologies, the New Ventures Director and team will launch a business development and marketing function for the spinout entity, including creation of a corporate brand, website, and relevant marketing assets.